SUZANNE E. BERNSTEIN

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder

T.A. Grady, Teresa A. Pigott, F L'Heureux et al. · American Journal of Psychiatry · 1993 · 120 citations

Fluoxetine-treated Patients, Psychiatry, Addiction +15

A Controlled Comparison of Adjuvant Lithium Carbonate or Thyroid Hormone in Clomipramine-Treated Patients with Obsessive-Compulsive Disorder

Teresa A. Pigott, Michele T. Pato, FRANCINE L HEUREUX et al. · Journal of Clinical Psychopharmacology · 1991 · 116 citations

Meaningful Change, Psychiatry, Addiction +15

A Double-Blind Study of Adjuvant Buspirone Hydrochloride in Clomipramine-Treated Patients with Obsessive-Compulsive Disorder

Teresa A. Pigott, James Hill, Katalin Bihari et al. · Current Opinion in Cardiology · 1992 · 116 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +16

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

Teresa A. Pigott, Joseph Zohar, James Hill et al. · Biological Psychiatry · 1991 · 114 citations

Neuroendocrine Effects, Psychoactive Drug, Psychiatry +12

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP

Teresa A. Pigott, James Hill, Tana A. Grady et al. · Biological Psychiatry · 1993 · 99 citations

Psychiatry, Iv Mcpp, Addiction +14